Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hourmant

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|June 13, 1987
Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2J P Soulillou, P Peyronnet, B Le Mauff, et al.
Clinical Transplants|January 1, 1996
Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapyM Giral, C Taddei, J M Nguyen, et al.
Kidney International. Supplement|January 1, 1996
A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipientsB Le Mauff, Y Le Meur, M Hourmant, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
Transplantation|August 15, 1994
Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot studyM Hourmant, B Le Mauff, Y Le Meur, et al.
Transplantation Proceedings|April 1, 1988
Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptorP Peyronnet, B Le Mauff, M Hourmant, et al.
Transplantation|June 1, 1992
Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferationG Blancho, F Buzelin, J Dantal, et al.
Transplantation Proceedings|February 1, 1993
One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of ageD Cantarovich, T Baranger, A Tirouvanziam, et al.
Transplantation Proceedings|February 1, 1989
Use of rabbit globulin anti-CD4+ lymphocyte clone derived from a rejected kidney in the prevention of rejection in kidney transplantation: a pilot studyM Hourmant, F Babinet, D Cantarovich, et al.
Transplantation|August 1, 1989
Polyclonal rabbit gamma globulins against a human cytotoxic CD4 T cell clone. II. Use in prevention of rejection in kidney transplantation: a pilot studyM Hourmant, F Babinet, D Cantarovich, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|June 13, 1987
Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2J P Soulillou, P Peyronnet, B Le Mauff, et al.
Clinical Transplants|January 1, 1996
Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapyM Giral, C Taddei, J M Nguyen, et al.
Kidney International. Supplement|January 1, 1996
A dose-searching trial of an anti-LFA1 monoclonal antibody in first kidney transplant recipientsB Le Mauff, Y Le Meur, M Hourmant, et al.
Transplantation|August 1, 1991
Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantationB Le Mauff, M Hourmant, J P Rougier, et al.
Transplantation|August 15, 1994
Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot studyM Hourmant, B Le Mauff, Y Le Meur, et al.
Transplantation Proceedings|April 1, 1988
Prophylactic treatment of human kidney allograft recipients with a monoclonal antibody (33B3.1) directed against interleukin 2 receptorP Peyronnet, B Le Mauff, M Hourmant, et al.
Transplantation|June 1, 1992
Evidence that early acute renal failure may be mediated by CD3- CD16+ cells in a kidney graft recipient with large granular lymphocyte proliferationG Blancho, F Buzelin, J Dantal, et al.
Transplantation Proceedings|February 1, 1993
One-hundred and five cadaveric kidney transplants with cyclosporine in recipients more than 60 years of ageD Cantarovich, T Baranger, A Tirouvanziam, et al.
Transplantation Proceedings|February 1, 1989
Use of rabbit globulin anti-CD4+ lymphocyte clone derived from a rejected kidney in the prevention of rejection in kidney transplantation: a pilot studyM Hourmant, F Babinet, D Cantarovich, et al.
Transplantation|August 1, 1989
Polyclonal rabbit gamma globulins against a human cytotoxic CD4 T cell clone. II. Use in prevention of rejection in kidney transplantation: a pilot studyM Hourmant, F Babinet, D Cantarovich, et al.
Pageof 10